Armistice Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.8M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $24.2M | Sell |
|
|||||
|
2024
Q4 | $90.2M | Buy |
|
|||||
|
2024
Q3 | $21.5M | Buy |
|
|||||
|
2024
Q2 | $16.9M | Sell |
|
|||||
|
2024
Q1 | $21.7M | Sell |
|
|||||
|
2023
Q4 | $39.9M | Sell |
|
|||||
|
2023
Q3 | $40.4M | Sell |
|
|||||
|
2023
Q2 | $43.6M | Sell |
|
|||||
|
2023
Q1 | $69.3M | Buy |
|
|||||
|
2022
Q4 | $42.7M | Sell |
|
|||||
|
2022
Q3 | $43.4M | Sell |
|
|||||
|
2022
Q2 | $87.9K | Buy |
|
|||||
|
2022
Q1 | $61.6M | Sell |
|
|||||
|
2021
Q4 | $107M | Sell |
|
|||||
|
2021
Q3 | $115M | Buy |
|
|||||
|
2021
Q2 | $121M | Buy |
|
|||||
|
2021
Q1 | $84.2M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $14.2M | Buy |
|
|||||
|
2019
Q3 | $5.08M | Buy |
|